Related Experiment Video
Updated: Nov 26, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.0K
Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives
Anjie Feng1, Shanjing Yang1, Yue Sun1
1School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Biomed Research International
|December 10, 2020
Summary
Oleanolic acid, a plant compound, faces formulation challenges due to poor solubility. Modern techniques create new oleanolic acid dosage forms and derivatives, enhancing bioavailability for drug development.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Oleanolic acid is a widely distributed pentacyclic triterpenoid with significant pharmacological activities.
- Its poor water solubility and bioavailability hinder direct application as a pharmaceutical agent.
- Structural limitations of oleanolic acid necessitate advanced formulation strategies for drug development.
Purpose of the Study:
- To review recent advancements in oleanolic acid dosage forms and derivatives.
- To provide a comprehensive evaluation of these preparations regarding characterization and pharmacokinetics.
- To offer insights and references for future oleanolic acid-based drug development.
Main Methods:
- Literature review of modern preparation techniques for oleanolic acid.
- Synthesis and design of novel oleanolic acid derivatives and dosage forms.
- Pharmacokinetic and characterization studies of developed oleanolic acid products.
Main Results:
- Various oleanolic acid dosage forms and derivatives have been successfully designed and synthesized.
- These novel preparations demonstrate improved water solubility and bioavailability compared to native oleanolic acid.
- Characterization and pharmacokinetic data support the potential of these formulations for therapeutic use.
Conclusions:
- Modern preparation techniques effectively overcome the limitations of oleanolic acid.
- Developed oleanolic acid dosage forms and derivatives show promise for new drug development.
- This review provides valuable references for researchers in the field of oleanolic acid-based therapeutics.
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
76
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
76
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
94
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
94
01:26Drug Administration and Therapy Phases: Overview
988
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
988
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
86
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
86
01:28Dosage Regimens: Designs and Approaches
134
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
134
01:28Preclinical Development: Overview
5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K